New Ask Claude or ChatGPT about any stock, using Bullpen. Bullpen in Claude or ChatGPT. 7 days free
Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Tuesday, November 10, 2026

Back to the front page

Seed Corn

Chiron’s failed $49 million Beaumont sale and $178 million Pinnacle acquisition leave XRN with $70 million of liquidity and medical-office assets to fund future deals.

XRN $372M
Orphan REITs 2 clicks

From X

@david_katunaric

Mikro Kap David on X

One data point that has kept me from ever seriously looking at $DOUG, despite the stock always looking cheap, is that there are three stores within a few minutes' walk of each other in central Zagreb (where I live) and somehow all three are always empty. Gf says the selection is poor, that she doesn't know anyone who shops there, and that it's basically "a 5x worse Sephora." No idea if that's representative of other markets...
@majgeoinvesting

Maj Soueidan on X

Almost got super excited about $AEYE Q3 inflection to profitability that they reported. There’s also been some major insider buying and they’re buying back a good deal of stock. However, these fuckers use EBITDA as their adjusted EPS - a little sneaky. I’m still watching, but not nearly as excited as I was. I mean, it’s still a potential breakout because the company reported a GAAP profit for the first time in its recent history. So, you can potentially value the company on price or EV to revenue, which is looks to be around 4x, which seems about fair. EV/EBITDA is around 13x. They sells software and services that help businesses make websites accessible to people with disabilities and just launched “Agentic Audits and tools” that integrate accessibility intelligence into AI coding workflows Need to figure out where revenue has to get to in order to get to profitability on a real adjusted income basis and if analyst estimates are GAAP or adjusted EPS and not EBITDA. Shame on analysts if they’re using EBITDA. @MicrocapDr It appears that they are - looks like they’re just using the company’s adjusted EBITDA guidance.😂 lazy If you look at the GAAP history, they’ve been losing a ton of money, but the estimates (in green) are much higher. Financial matrix source: @InfoArbMonitor

Investor Letters

All letters

Post Q3 EVC Update

EVC's Q3 update cites $30 million for a single station, a broadcast-business sale and stronger positioning for 2027.

EVC $832M
Nat Stewart - Stock Picking Newsletter 26 clicks

Entravision Q3 Update

Entravision’s Q3 ad-tech revenue reached $177.2 million, up 133% year over year, while total revenue rose 88% to $226.3 million and diluted…

EVC $832M
The Value Road 4 clicks

GREAT DEC-TECTIVE WORK

Diversified Energy reported $255.6 million of “true” nine-month free cash flow, while its $1.8 billion Birch acquisition would shift…

DEC $900M
The Oak Bloke 4 clicks

Research Note

Nine Mile Metals is the subject of a research note.

VMSXF $14M
Atrium Research - Equity Research 5 clicks

Site Centers (NYSE:SITC)

Site Centers' $3 per-share return-of-capital distribution and December delisting leave a discounted liquidation stub, with two properties…

SITC $37M
Real Assets, Real Value 5 clicks

Notes and Updates

ECIP recipient banks could repurchase Treasury preferred shares at steep discounts, potentially lifting book value, while Hawaiian Electric…

UBAB $190M
Exploring with Alluvial Capital

Mereo Biopharma

Mereo Biopharma has two late-stage assets, seeks non-dilutive financing for alvelestat Phase 3 trials, and reports cash runway through 2027.

MREO $44M
Raging Bull Investments

Revisiting An Old Idea

Instil Bio leased its 128,000-square-foot Tarzana life-sciences building to AstraZeneca for 15 years at $7.52 million annual rent,…

TIL $47M
Raging Bull Investments

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 79 of 281

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

360 firms

Sectors

Ordered by how often our editor reaches for them.